26 Det er sandsynligt, at intermitterende behandling kan øge risikoen for at udvikle sensibilisering og dermed forekomst af klinisk betydende overfølsomhedsreaktioner.
It is likely that intermittent therapy may increase the risk of developing sensitisation and therefore occurrence of clinically significant hypersensitivity reactions.